Zobrazeno 1 - 10
of 85
pro vyhledávání: '"H, Dafni"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Introduction: Clinical and laboratory parameters associated with response for patients with advanced pre-treated malignant pleural mesothelioma (MPM) are lacking. We aimed to identify prognostic and predictive markers among patients with relapsed MPM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7c14b050adb683a09ecdb67e64f16ca5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220316
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220316
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Latin America and the Caribbean have not yet developed strong clinical cancer research programmes. In order to improve this situation two international cancer organisations, the Latin American Society of Clinical Oncology (SLACOM) and the European So
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::4144c3b8f08db821e6bc705f69e160e5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086333
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086333
To explore the impact of dose intensity (DI) in the adjuvant setting of breast cancer, a randomized phase III trial was conducted comparing postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide, methotrexa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9fc08fa2f48b26bd25e411fdc7736343
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089527
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089527
Purpose: Interferon is approved for adjuvant treatment of patients with stage IIb/III melanoma. The toxicity and uncertainty regarding survival benefits of interferon have qualified its acceptance, despite significant durable relapse prevention in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3edb26a9ddd9e0d97f2f9942a9cf04cf
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089902
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089902
Background: To assess the prognostic and predictive significance of HER-1/EGFR protein levels in high-risk patients with breast cancer treated with dose-dense sequential adjuvant chemotherapy. Methods: 595 high-risk breast cancer patients were treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::28b14d802a810ea925c1f320ed79a312
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3095368
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3095368
Purpose: To assess the prognostic and predictive significance of p53 and Bcl-2 protein expression in high risk patients with breast cancer treated with dose-dense sequential chemotherapy. Patients and methods: From June 1997 until November 2000, 595
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0f5bebb03cc471152121c1c4a3b1831e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3113269
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3113269
BACKGROUND. Adverse effects of paclitaxel and carboplatin have been well described: however, pulmonary toxicity after patients receive this regimen has not been investigated extensively. METHODS. To clarify this issue, 33 consecutive patients who wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b2bc73ac821f99dbebd1bef7519bafe6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3081382
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3081382